| Date | Title | Description |
| 13.08.2026 | Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs | Khartis Therapeutics Raises $50M Series B
Khartis Therapeutics has raised $50 million in Series B funding to advance its oral medicine pipeline.mForge Life Science Partners led the round. Longwood Fund and Alexandria Venture Investments joi... |
| 19.05.2026 | Accro Bioscience: $50 Million Series C Raised To Advance Immune Mediated Disease Pipeline | Accro Bioscience announced the closing of a $50 million Series C financing round led by OrbiMed, with participation from TCG Crossover (TCGX), LAV, Cenova Capital, and existing investors Shenzhen Capital Group (SCGC) and Oriza Holdings.
The... |
| 19.05.2026 | Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases | Financing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and existing investors SCGC and Oriza
Proceeds will advance multi-asset pipeline including AC-101, a leading RIPK2 inhibitor for Ulcerative Colitis
NEW YORK and SUZH... |
| 25.04.2026 | Pulnovo Medical: $100 Million Financing Round Led By Medtronic Closed | Pulnovo Medical, a New York-based pioneer in breakthrough therapies for pulmonary hypertension and heart failure, has completed an oversubscribed $100 million strategic financing round led by Medtronic, one of the world’s largest medical te... |
| 20.04.2026 | Pulnovo Medical Raises $100M in Funding | Pulnovo Medical, a NYC-based developer of therapies for treating pulmonary hypertension and heart failure, raised $100M in funding.
The round was led by Medtronic, with participation from existing investors such as EQT, Qiming Venture Partn... |
| 03.04.2026 | China's BMI Frontier: StairMed Fuels Next-Gen Human-Machine Integration | StairMed secured RMB 500 million ($69M) from Alibaba, Tencent, and others. This investment accelerates brain-machine interface (BMI) and neuromodulation development. The company progresses 256-channel BMI clinical trials in China, pioneerin... |
| 02.04.2026 | StairMed: RMB 500 Million (About $69 Million) Raised For Brain Machine Interface Development | Shanghai-based StairMed has secured RMB 500 million in a new financing round led by Alibaba, with participation from existing investors including Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed, Qiming Venture Partners, Lilly Asia Vent... |
| 02.04.2026 | CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala | SHANGHAI, April 2, 2026 /PRNewswire/ -- The 12th Annual China Healthcare Investment Conference (CHIC 2026) capped the first day of its two-day program with a celebratory Awards Gala Dinner held at The Ritz-Carlton Hotel Pudong, Shanghai. Th... |
| 22.03.2026 | Excalipoint Therapeutics Secures $68.7M for Next-Gen TCE Therapies | Excalipoint Therapeutics, a dynamic Shanghai-based biotechnology firm, secured $68.7 million in oversubscribed seed funding. This substantial capital propels its mission to redefine T-cell engager (TCE) therapies. The company is tackling si... |
| 18.03.2026 | Excalipoint Therapeutics: $68.7 Million Raised For Next-Generation T-Cell Engager Therapies | Excalipoint Therapeutics, a clinical-stage biotechnology company focused on next-generation T-cell engager therapies, announced the close of an oversubscribed $68.7 million seed financing round to advance its proprietary platforms and pipel... |
| 13.03.2026 | Alibaba leads RMB 500 million investment in BCI startup StairMed | StairMed, a brain-computer interface (BCI) developer, has secured RMB 500 million (USD 72.7 million) in a funding round led by Alibaba Group, with participation from SDIC Unity Capital. Existing investors including Tencent, FountainBridge C... |
| 17.11.2025 | Chinese Drugmakers Rush to List in Hong Kong Amid Strong Investor Interest | (Yicai) Nov. 17 -- Chinese drugmakers are flocking to list in Hong Kong this year, driven by strong investor interest, recent stock market gains, overseas licensing deals, and regulatory reforms, though cornerstone investors are becoming mo... |
| 03.10.2025 | Avenzo Therapeutics Secures $60 Million Series B to Advance Oncology Breakthroughs | Avenzo Therapeutics secured $60 million in Series B funding. This propels their oncology pipeline. The San Diego biotech now totals $446 million raised. OrbiMed and SR One led the round. New investor Longwood Fund joined. Key existing backe... |
| 23.09.2025 | Avenzo: $60 Million Series B Secured For Developing Oncology Therapies | Avenzo Therapeutics, a biotechnology company focused on developing new cancer treatments, has announced the closing of a $60 million Series B funding round. This latest investment follows a previous $386 million raised through its Series A ... |
| 22.09.2025 | Avenzo Therapeutics Raised $60M in Series B Funding | Avenzo Therapeutics, a San Diego, CA-based clinical-stage biotechnology company developing new oncology therapies, raised $60M in Series B funding.
The round was led by OrbiMed and SR One, with participation from new investor Longwood Fund,... |
| 06.09.2025 | Ronovo Surgical: $67 Million Series D Raised For Advancing Modular Robotic Surgery | Ronovo Surgical has announced the closing of its Series D financing round, bringing in $67 million in new capital. The round was led by Johnson & Johnson’s corporate venture arm, JJDC, and included participation from Lilly Asia Ventures... |
| 16.05.2025 | Lilly Asia Ventures closes seventh USD fund, rakes in over $547m | Dual-currency biomedical venture firm Lily Asia Ventures (LAV) has closed its seventh USD fund, roping in sovereigns, pensions, endowments, foundations, family offices and funds of funds. |
| 13.02.2025 | New Blood in Innovation: Frank Yin Joins Washington Research Foundation | In the bustling world of innovation, fresh talent can spark a revolution. Frank Yin, Ph.D., is the latest addition to the Washington Research Foundation (WRF) as an investment associate. His mission? To unearth and nurture startup opportuni... |
| 13.02.2025 | Frank Yin joins Washington Research Foundation staff as investment associate | Washington Research Foundation
Yin's role will primarily focus on identifying and evaluating startup investment opportunities to advance Washington state innovations for public benefit
SEATTLE, Feb. 13, 2025 /PRNewswire-PRWeb/ -- Frank Yin,... |
| 13.01.2025 | Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders | Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-c... |
| 10.05.2021 | Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases | SHANGHAI, May 10, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chroni... |
| 26.07.2016 | Gates Foundation leads $14M funding round for Just Biotherapeutics to battle infectious diseases | Just Biotherapeutics CEO and Founding Partner Jim Thomas
Seattle-based Just Biotherapeutics said Monday it closed a $14 million funding round led by the Bill & Melinda Gates Foundation.
A group of former Amgen scientists founded Just in... |
| 06.01.2016 | Daily funding roundup - January 6, 2016 | Flatiron Health bagged $175M; NextCure, Inc. raised $67M; AirCloset received $8M funding
Ossia, a Bellevue, WA-based maker of a wireless power technology, received a strategic investment from Molex, LLC, a global manufacturer of electronic ... |
| 29.10.2015 | MabSpace Biosciences Completes $15M Series A Financing | MabSpace Biosciences Co., Ltd., a Suzhou, China-based company focused on the discovery and development of antibody-based therapeutics, completed a $15m Series A financing.
Lilly Asia Ventures was the sole investor for the round.
Led by Dr. ... |
| 21.09.2015 | Daily funding roundup - September 21, 2015 | Deciphera bagged $75M; Portea raised $37.5M; Just Biotherapeutics secured $15M
BidFlyer, an Israeli startup that is a white-label platform for airlines, has raised $1 million in funding for its business model, which involves putting small b... |
